{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T21:58:28Z","timestamp":1767650308251,"version":"3.40.3"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T00:00:00Z","timestamp":1620432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T00:00:00Z","timestamp":1620432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Children's Tumour Foundation Grant"},{"name":"The honourable Brad Hazzard"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s10689-021-00259-9","type":"journal-article","created":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T03:33:29Z","timestamp":1620444809000},"page":"241-253","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The psychological impact and experience of breast cancer screening in young women with an increased risk of breast cancer due to neurofibromatosis type 1"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5578-0460","authenticated-orcid":false,"given":"Ashley","family":"Crook","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebekah","family":"Kwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Ephraums","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathilda","family":"Wilding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lavvina","family":"Thiyagarajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1164-2386","authenticated-orcid":false,"given":"Jane","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrina","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2495-4928","authenticated-orcid":false,"given":"Yemima","family":"Berman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,8]]},"reference":[{"issue":"9","key":"259_CR1","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1038\/bjc.2015.78","volume":"112","author":"OO Seminog","year":"2015","unstructured":"Seminog OO, Goldacre MJ (2015) Age-specific risk of breast cancer in women with neurofibromatosis type 1. Br J Cancer 112(9):1546\u20131548. https:\/\/doi.org\/10.1038\/bjc.2015.78","journal-title":"Br J Cancer"},{"key":"259_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s13053-019-0110-z","author":"LP Suarez-Kelly","year":"2019","unstructured":"Suarez-Kelly LP, Yu L, Kline D, Schneider EB, Agnese DM, Carson WE (2019) Increased breast cancer risk in women with neurofibromatosis type 1: a meta-analysis and systematic review of the literature. Hered Cancer Clin Pract. https:\/\/doi.org\/10.1186\/s13053-019-0110-z","journal-title":"Hered Cancer Clin Pract"},{"issue":"2","key":"259_CR3","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/bjc.2016.403","volume":"116","author":"E Uusitalo","year":"2017","unstructured":"Uusitalo E, Kallionpaa RA, Kurki S et al (2017) Breast cancer in neurofibromatosis type 1: overrepresentation of unfavourable prognostic factors. Br J Cancer 116(2):211\u2013217. https:\/\/doi.org\/10.1038\/bjc.2016.403","journal-title":"Br J Cancer"},{"issue":"1","key":"259_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.6004\/jnccn.2017.0003","volume":"15","author":"MB Daly","year":"2017","unstructured":"Daly MB, Pilarski R, Berry M et al (2017) NCCN Guidelines Insights: Genetic\/Familial High-Risk Assessment: breast and ovarian, version 2.2017. J Natl Compr Canc Netw 15(1):9\u201320. https:\/\/doi.org\/10.6004\/jnccn.2017.0003","journal-title":"J Natl Compr Canc Netw"},{"issue":"7","key":"259_CR5","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/gim.2018.28","volume":"20","author":"DR Stewart","year":"2018","unstructured":"Stewart DR, Korf BR, Nathanson KL, Stevenson DA, Yohay K (2018) Care of adults with neurofibromatosis type 1: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med 20(7):671\u2013682. https:\/\/doi.org\/10.1038\/gim.2018.28","journal-title":"Genet Med"},{"key":"259_CR6","unstructured":"NSW Cancer Institute (2020) NF1 (Neurofibromatosis type 1)\u2014risk management. vol. 14\/11, NSW Government, https:\/\/eviq.org.au\/cancer-genetics\/adult\/risk-management\/752-nf1-neurofibromatosis-type-1-risk-manageme. Accessed 3 Dec 2020"},{"issue":"2","key":"259_CR7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1136\/jmg.2006.045906","volume":"44","author":"RE Ferner","year":"2007","unstructured":"Ferner RE, Huson SM, Thomas N et al (2007) Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet 44(2):81\u201388. https:\/\/doi.org\/10.1136\/jmg.2006.045906","journal-title":"J Med Genet"},{"issue":"12","key":"259_CR8","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1002\/ajmg.a.35550","volume":"158","author":"SA Madanikia","year":"2012","unstructured":"Madanikia SA, Bergner A, Ye X, Blakeley JON (2012) Increased risk of breast cancer in women with NF1. Am J Med Genet A 158(12):3056\u20133060. https:\/\/doi.org\/10.1002\/ajmg.a.35550","journal-title":"Am J Med Genet A"},{"issue":"17","key":"259_CR9","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1200\/JCO.2015.65.3576","volume":"34","author":"E Uusitalo","year":"2016","unstructured":"Uusitalo E, Rantanen M, Kallionp\u00e4\u00e4 RA et al (2016) Distinctive cancer associations in patients with neurofibromatosis type 1. J Clin Oncol 34(17):1978\u20131986. https:\/\/doi.org\/10.1200\/JCO.2015.65.3576","journal-title":"J Clin Oncol"},{"issue":"2","key":"259_CR10","first-page":"305","volume":"53","author":"DF Easton","year":"1993","unstructured":"Easton DF, Ponder MA, Huson SM, Ponder BA (1993) An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes. Am J Hum Genet 53(2):305\u2013313","journal-title":"Am J Hum Genet"},{"key":"259_CR11","doi-asserted-by":"crossref","unstructured":"(1988) Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol 45(5):575\u2013578. https:\/\/pubmed.ncbi.nlm.nih.gov\/3128965\/","DOI":"10.1001\/archneur.1988.00520290115023"},{"issue":"6","key":"259_CR12","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s10897-015-9829-5","volume":"24","author":"H Crawford","year":"2015","unstructured":"Crawford H, Barton B, Wilson M et al (2015) The impact of neurofibromatosis type 1 on the health and wellbeing of Australian adults. J Genet Couns 24(6):931\u2013944. https:\/\/doi.org\/10.1007\/s10897-015-9829-5","journal-title":"J Genet Couns"},{"issue":"8","key":"259_CR13","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/S1474-4422(14)70063-8","volume":"13","author":"AC Hirbe","year":"2014","unstructured":"Hirbe AC, Gutmann DH (2014) Neurofibromatosis type 1: a multidisciplinary approach to care. Lancet Neurol 13(8):834\u2013843. https:\/\/doi.org\/10.1016\/S1474-4422(14)70063-8","journal-title":"Lancet Neurol"},{"issue":"6","key":"259_CR14","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1177\/1087054711433422","volume":"17","author":"AK Templer","year":"2013","unstructured":"Templer AK, Titus JB, Gutmann DH (2013) A neuropsychological perspective on attention problems in neurofibromatosis type 1. J Atten Disord 17(6):489\u2013496. https:\/\/doi.org\/10.1177\/1087054711433422","journal-title":"J Atten Disord"},{"key":"259_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-017-0607-y","author":"R Ferner","year":"2017","unstructured":"Ferner R, Thomas M, Mercer G et al (2017) Evaluation of quality of life in adults with neurofibromatosis 1 (NF1) using the Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire. Health Qual Life Outcomes. https:\/\/doi.org\/10.1186\/s12955-017-0607-y","journal-title":"Health Qual Life Outcomes"},{"key":"259_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-85729-629-0","volume-title":"Neurofibromatoses in clinical practice","author":"RE Ferner","year":"2011","unstructured":"Ferner RE (2011) Neurofibromatoses in clinical practice. Springer, London"},{"issue":"2","key":"259_CR17","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1159\/000337548","volume":"224","author":"S Granstr\u00f6m","year":"2012","unstructured":"Granstr\u00f6m S, Langenbruch A, Augustin M, Mautner V-F (2012) Psychological burden in adult neurofibromatosis type 1 patients: impact of disease visibility on body image. Dermatology 224(2):160\u2013167. https:\/\/doi.org\/10.1159\/000337548","journal-title":"Dermatology"},{"issue":"5","key":"259_CR18","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/cge.12551","volume":"88","author":"JS Cohen","year":"2015","unstructured":"Cohen JS, Levy HP, Sloan J, Dariotis J, Biesecker BB (2015) Depression among adults with neurofibromatosis type 1: prevalence and impact on quality of life. Clin Genet 88(5):425\u2013430. https:\/\/doi.org\/10.1111\/cge.12551","journal-title":"Clin Genet"},{"issue":"1\u20132","key":"259_CR19","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0022-510X(96)00022-6","volume":"138","author":"RE Ferner","year":"1996","unstructured":"Ferner RE, Hughes RAC, Weinman J (1996) Intellectual impairment in neurofibromatosis 1. J Neurol Sci 138(1\u20132):125\u2013133. https:\/\/doi.org\/10.1016\/0022-510X(96)00022-6","journal-title":"J Neurol Sci"},{"key":"259_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-019-1338-y","author":"A Sanagoo","year":"2019","unstructured":"Sanagoo A, Jouybari L, Koohi F, Sayehmiri F (2019) Evaluation of QoL in neurofibromatosis patients: a systematic review and meta-analysis study. (Report). BMC Neurol. https:\/\/doi.org\/10.1186\/s12883-019-1338-y","journal-title":"BMC Neurol"},{"issue":"Supplement_1","key":"259_CR21","doi-asserted-by":"publisher","first-page":"i141","DOI":"10.1093\/noajnl\/vdaa003","volume":"2","author":"G Hamoy-Jimenez","year":"2020","unstructured":"Hamoy-Jimenez G, Kim R, Suppiah S, Zadeh G, Bril V, Barnett C (2020) Quality of life in patients with neurofibromatosis type 1 and 2 in Canada. Neuro-Oncol Adv 2(Supplement_1):i141\u2013i149. https:\/\/doi.org\/10.1093\/noajnl\/vdaa003","journal-title":"Neuro-Oncol Adv"},{"issue":"8","key":"259_CR22","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1136\/jmg.2007.049346","volume":"44","author":"S Sharif","year":"2007","unstructured":"Sharif S, Moran A, Huson SM et al (2007) Women with neurofibromatosis 1 are at a moderately increased risk of developing breast cancer and should be considered for early screening. J Med Genet 44(8):481. https:\/\/doi.org\/10.1136\/jmg.2007.049346","journal-title":"J Med Genet"},{"issue":"1","key":"259_CR23","doi-asserted-by":"publisher","first-page":"E8","DOI":"10.3171\/2009.11.Focus09221","volume":"28","author":"ON Gottfried","year":"2010","unstructured":"Gottfried ON, Viskochil DH, Couldwell WT (2010) Neurofibromatosis type 1 and tumorigenesis: molecular mechanisms and therapeutic implications. Neurosurg Focus 28(1):E8. https:\/\/doi.org\/10.3171\/2009.11.Focus09221","journal-title":"Neurosurg Focus"},{"issue":"3","key":"259_CR24","doi-asserted-by":"publisher","first-page":"583","DOI":"10.4103\/0973-1482.196761","volume":"13","author":"D Pradhan","year":"2017","unstructured":"Pradhan D, Kaur N, Gami A, Hura KS, Garg G, Mohanty SK (2017) Neurofibromatosis and breast cancer: do we need to revise the mammographic screening schedule in patients of neurofibromatosis? J Cancer Res Ther 13(3):583\u2013585. https:\/\/doi.org\/10.4103\/0973-1482.196761","journal-title":"J Cancer Res Ther"},{"issue":"3","key":"259_CR25","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s10549-018-4851-6","volume":"171","author":"YS Yap","year":"2018","unstructured":"Yap YS, Munusamy P, Lim C et al (2018) Breast cancer in women with neurofibromatosis type 1 (NF1): a comprehensive case series with molecular insights into its aggressive phenotype. Breast Cancer Res Treat 171(3):719\u2013735. https:\/\/doi.org\/10.1007\/s10549-018-4851-6","journal-title":"Breast Cancer Res Treat"},{"key":"259_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11050707","author":"N Maani","year":"2019","unstructured":"Maani N, Westergard S, Yang J et al (2019) NF1 patients receiving breast cancer screening: insights from the Ontario High Risk Breast Screening Program. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers11050707","journal-title":"Cancers (Basel)"},{"issue":"2","key":"259_CR27","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41436-019-0651-6","volume":"22","author":"DGR Evans","year":"2020","unstructured":"Evans DGR, Kallionpaa RA, Clementi M et al (2020) Breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort study. Genet Med 22(2):398\u2013406. https:\/\/doi.org\/10.1038\/s41436-019-0651-6","journal-title":"Genet Med"},{"issue":"1","key":"259_CR28","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12885-015-1215-z","volume":"15","author":"AV Da Silva","year":"2015","unstructured":"Da Silva AV, Rodrigues FR, Pureza M, Lopes VGS, Cunha KS (2015) Breast cancer and neurofibromatosis type 1: a diagnostic challenge in patients with a high number of neurofibromas. BMC Cancer 15(1):183. https:\/\/doi.org\/10.1186\/s12885-015-1215-z","journal-title":"BMC Cancer"},{"issue":"11","key":"259_CR29","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/ejhg.2011.113","volume":"19","author":"DG Evans","year":"2011","unstructured":"Evans DG, O\u2019Hara C, Wilding A et al (2011) Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989. Eur J Hum Genet 19(11):1187\u20131191. https:\/\/doi.org\/10.1038\/ejhg.2011.113","journal-title":"Eur J Hum Genet"},{"issue":"3","key":"259_CR30","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/cge.12627","volume":"89","author":"HA Crawford","year":"2016","unstructured":"Crawford HA, Barton B, Wilson MJ et al (2016) Uptake of health monitoring and disease self-management in Australian adults with neurofibromatosis type 1: strategies to improve care. Clin Genet 89(3):385\u2013391. https:\/\/doi.org\/10.1111\/cge.12627","journal-title":"Clin Genet"},{"key":"259_CR31","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1377\/hlthaff.2012.1061","volume":"32","author":"J Hibbard","year":"2013","unstructured":"Hibbard J, Greene J (2013) What the evidence shows about patient activation: better health outcomes and care experiences; Fewer data on costs. Health Aff 32:207\u2013214","journal-title":"Health Aff"},{"issue":"4","key":"259_CR32","doi-asserted-by":"publisher","first-page":"256","DOI":"10.7326\/M15-0970","volume":"164","author":"HD Nelson","year":"2016","unstructured":"Nelson HD, Pappas M, Cantor A, Griffin J, Daeges M, Humphrey L (2016) Harms of breast cancer screening: systematic review to update the 2009 US Preventive Services Task Force Recommendation. Ann Intern Med 164(4):256. https:\/\/doi.org\/10.7326\/M15-0970","journal-title":"Ann Intern Med"},{"issue":"6","key":"259_CR33","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1136\/jech.51.6.705","volume":"51","author":"W Scaf-Klomp","year":"1997","unstructured":"Scaf-Klomp W, Sanderman R, van de Wiel HB, Otter R, van Den Heuvel WJ (1997) Distressed or relieved? Psychological side effects of breast cancer screening in The Netherlands. J Epidemiol Community Health 51(6):705. https:\/\/doi.org\/10.1136\/jech.51.6.705","journal-title":"J Epidemiol Community Health"},{"issue":"12","key":"259_CR34","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1002\/pon.1355","volume":"17","author":"K Brain","year":"2008","unstructured":"Brain K, Henderson BJ, Tyndel S et al (2008) Predictors of breast cancer-related distress following mammography screening in younger women on a family history breast screening programme. Psychooncology 17(12):1180\u20131188. https:\/\/doi.org\/10.1002\/pon.1355","journal-title":"Psychooncology"},{"issue":"9855","key":"259_CR35","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1016\/S0140-6736(12)61611-0","volume":"380","author":"Independent Uk Panel On Breast Cancer S","year":"2012","unstructured":"Independent Uk Panel On Breast Cancer S (2012) The benefits and harms of breast cancer screening: an independent review. The Lancet 380(9855):1778\u20131786. https:\/\/doi.org\/10.1016\/S0140-6736(12)61611-0","journal-title":"The Lancet"},{"issue":"10","key":"259_CR36","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.ejca.2005.03.020","volume":"41","author":"S van Dooren","year":"2005","unstructured":"van Dooren S, Seynaeve C, Rijnsburger AJ et al (2005) Exploring the course of psychological distress around two successive control visits in women at hereditary risk of breast cancer. Eur J Cancer 41(10):1416\u20131425. https:\/\/doi.org\/10.1016\/j.ejca.2005.03.020","journal-title":"Eur J Cancer"},{"issue":"1","key":"259_CR37","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1093\/jnci\/84.1.24","volume":"84","author":"KM Kash","year":"1992","unstructured":"Kash KM, Holland JC, Halper MS, Miller DG (1992) Psychological distress and surveillance behaviors of women with a family history of breast cancer. J Natl Cancer Inst 84(1):24\u201330. https:\/\/doi.org\/10.1093\/jnci\/84.1.24","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"259_CR38","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/sj.bjc.6601912","volume":"91","author":"AJ Rijnsburger","year":"2004","unstructured":"Rijnsburger AJ, Essink-Bot ML, van Dooren S et al (2004) Impact of screening for breast cancer in high-risk women on health-related quality of life. Br J Cancer 91(1):69\u201376. https:\/\/doi.org\/10.1038\/sj.bjc.6601912","journal-title":"Br J Cancer"},{"issue":"5","key":"259_CR39","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.breast.2011.04.004","volume":"20","author":"TN Spiegel","year":"2011","unstructured":"Spiegel TN, Esplen MJ, Hill KA, Wong J, Causer PA, Warner E (2011) Psychological impact of recall on women with BRCA mutations undergoing MRI surveillance. Breast 20(5):424\u2013430. https:\/\/doi.org\/10.1016\/j.breast.2011.04.004","journal-title":"Breast"},{"issue":"4","key":"259_CR40","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/bjc.2011.1","volume":"104","author":"J Hutton","year":"2011","unstructured":"Hutton J, Walker LG, Gilbert FJ et al (2011) Psychological impact and acceptability of magnetic resonance imaging and X-ray mammography: the MARIBS Study. Br J Cancer 104(4):578\u2013586. https:\/\/doi.org\/10.1038\/bjc.2011.1","journal-title":"Br J Cancer"},{"issue":"2","key":"259_CR41","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.canep.2010.07.012","volume":"35","author":"N Pashayan","year":"2011","unstructured":"Pashayan N, Pharoah P, Tab\u00e1r L et al (2011) Validation of a modelling approach for estimating the likely effectiveness of cancer screening using cancer data on prevalence screening and incidence. Cancer Epidemiol 35(2):139\u2013144. https:\/\/doi.org\/10.1016\/j.canep.2010.07.012","journal-title":"Cancer Epidemiol"},{"issue":"2","key":"259_CR42","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1200\/JCO.2009.22.7991","volume":"28","author":"AW Kurian","year":"2010","unstructured":"Kurian AW, Sigal BM, Plevritis SK (2010) Survival analysis of cancer risk reduction strategies for BRCA1\/2 mutation carriers. J Clin Oncol 28(2):222\u2013231. https:\/\/doi.org\/10.1200\/JCO.2009.22.7991","journal-title":"J Clin Oncol"},{"issue":"7","key":"259_CR43","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1002\/ijc.29534","volume":"137","author":"S Saadatmand","year":"2015","unstructured":"Saadatmand S, Obdeijn IM, Rutgers EJ et al (2015) Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC). Int J Cancer 137(7):1729\u20131738. https:\/\/doi.org\/10.1002\/ijc.29534","journal-title":"Int J Cancer"},{"key":"259_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s13053-016-0048-3","author":"DG Evans","year":"2016","unstructured":"Evans DG, Harkness EF, Howell A et al (2016) Intensive breast screening in BRCA2 mutation carriers is associated with reduced breast cancer specific and all cause mortality. Hered Cancer Clin Pract. https:\/\/doi.org\/10.1186\/s13053-016-0048-3","journal-title":"Hered Cancer Clin Pract"},{"issue":"11","key":"259_CR45","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/jama.292.11.1317","volume":"292","author":"E Warner","year":"2004","unstructured":"Warner E, Plewes DB, Hill KA et al (2004) Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 292(11):1317\u20131325. https:\/\/doi.org\/10.1001\/jama.292.11.1317","journal-title":"JAMA"},{"issue":"3","key":"259_CR46","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/(SICI)1099-1611(199609)5:3<259::AID-PON204>3.0.CO;2-O","volume":"5","author":"P Gagnon","year":"1996","unstructured":"Gagnon P, Massie MJ, Kash KM et al (1996) Perception of breast cancer risk and psychological distress in women attending a surveillance program. Psychooncology 5(3):259\u2013269. https:\/\/doi.org\/10.1002\/(SICI)1099-1611(199609)5:3%3c259::AID-PON204%3e3.0.CO;2-O","journal-title":"Psychooncology"},{"issue":"3","key":"259_CR47","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s10689-008-9182-z","volume":"7","author":"J Reichelt","year":"2008","unstructured":"Reichelt J, M\u00f8ller P, Heimdal K, Dahl A (2008) Psychological and cancer-specific distress at 18 months post-testing in women with demonstrated BRCA1 mutations for hereditary breast\/ovarian cancer. Fam Cancer 7(3):245\u2013254. https:\/\/doi.org\/10.1007\/s10689-008-9182-z","journal-title":"Fam Cancer"},{"issue":"8","key":"259_CR48","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1002\/pon.4047","volume":"25","author":"IC Konings","year":"2016","unstructured":"Konings IC, Sidharta GN, Harinck F et al (2016) Repeated participation in pancreatic cancer surveillance by high-risk individuals imposes low psychological burden. Psychooncology 25(8):971\u2013978. https:\/\/doi.org\/10.1002\/pon.4047","journal-title":"Psychooncology"},{"issue":"6","key":"259_CR49","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361\u2013370. https:\/\/doi.org\/10.1111\/j.1600-0447.1983.tb09716.x","journal-title":"Acta Psychiatr Scand"},{"issue":"3","key":"259_CR50","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.2044-8260.1992.tb00997.x","volume":"31","author":"TM Marteau","year":"1992","unstructured":"Marteau TM, Bekker H (1992) The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). Br J Clin Psychol 31(3):301\u2013306. https:\/\/doi.org\/10.1111\/j.2044-8260.1992.tb00997.x","journal-title":"Br J Clin Psychol"},{"key":"259_CR51","volume-title":"Manual for the State-Trait anxiety","author":"C Spielberger","year":"1970","unstructured":"Spielberger C, Gorusch R, Lushene R (1970) Manual for the State-Trait anxiety. Consulting Psychologists Press, California"},{"key":"259_CR52","volume-title":"Manual for the State-Trait anxiety inventory\u2014form Y","author":"C Spielberger","year":"1983","unstructured":"Spielberger C, Gorusch R, Lushene R (1983) Manual for the State-Trait anxiety inventory\u2014form Y. Consulting Psychologists Press, Palo Alto, CA"},{"issue":"1","key":"259_CR53","doi-asserted-by":"publisher","first-page":"E44","DOI":"10.1097\/NCC.0b013e3182813a17","volume":"37","author":"EJA Custers","year":"2014","unstructured":"Custers EJA, Van Den Berg WS, Van Laarhoven MHW, Bleiker AEM, Gielissen MMF, Prins BJ (2014) The Cancer Worry Scale: detecting fear of recurrence in breast cancer survivors. Cancer Nurs 37(1):E44\u2013E50. https:\/\/doi.org\/10.1097\/NCC.0b013e3182813a17","journal-title":"Cancer Nurs"},{"issue":"3","key":"259_CR54","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/pon.1570","volume":"19","author":"KF Douma","year":"2010","unstructured":"Douma KF, Aaronson NK, Vasen HF et al (2010) Psychological distress and use of psychosocial support in familial adenomatous polyposis. Psychooncology 19(3):289\u2013298. https:\/\/doi.org\/10.1002\/pon.1570","journal-title":"Psychooncology"},{"key":"259_CR55","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/pon.2960030406","volume":"3","author":"DLG Walker","year":"1994","unstructured":"Walker DLG, Cordiner CM, Gilbert FJ et al (1994) How distressing is attendance for routine breast screening? Psychooncology 3:229\u2013304. https:\/\/doi.org\/10.1002\/pon.2960030406","journal-title":"Psychooncology"},{"issue":"12","key":"259_CR56","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1001\/jamaoncol.2017.1968","volume":"3","author":"ML Ballinger","year":"2017","unstructured":"Ballinger ML, Best A, Mai PL et al (2017) Baseline surveillance in Li-Fraumeni syndrome using whole-body magnetic resonance imaging: a meta-analysis. JAMA Oncol 3(12):1634\u20131639. https:\/\/doi.org\/10.1001\/jamaoncol.2017.1968","journal-title":"JAMA Oncol"},{"issue":"2","key":"259_CR57","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42(2):377\u2013381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010","journal-title":"J Biomed Inform"},{"issue":"2","key":"259_CR58","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s10549-008-0140-0","volume":"115","author":"S O\u2019Neill","year":"2009","unstructured":"O\u2019Neill S, Rubinstein W, Sener S et al (2009) Psychological impact of recall in high-risk breast MRI screening. Breast Cancer Res Treat 115(2):365\u2013371. https:\/\/doi.org\/10.1007\/s10549-008-0140-0","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"259_CR59","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/bju.14412","volume":"123","author":"EK Bancroft","year":"2019","unstructured":"Bancroft EK, Saya S, Page EC et al (2019) Psychosocial impact of undergoing prostate cancer screening for men with BRCA1 or BRCA2 mutations. BJU Int 123(2):284\u2013292. https:\/\/doi.org\/10.1111\/bju.14412","journal-title":"BJU Int"},{"issue":"3","key":"259_CR60","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10689-016-9964-7","volume":"16","author":"KA McBride","year":"2017","unstructured":"McBride KA, Ballinger ML, Schlub TE et al (2017) Psychosocial morbidity in TP53 mutation carriers: is whole-body cancer screening beneficial? Fam Cancer 16(3):423\u2013432. https:\/\/doi.org\/10.1007\/s10689-016-9964-7","journal-title":"Fam Cancer"},{"issue":"12","key":"259_CR61","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/gim.2012.85","volume":"14","author":"LW Daphne","year":"2012","unstructured":"Daphne LW, Kelly BS, Sonia E et al (2012) Emotional functioning of patients with neurofibromatosis tumor suppressor syndrome. Genet Med 14(12):977. https:\/\/doi.org\/10.1038\/gim.2012.85","journal-title":"Genet Med"},{"issue":"7","key":"259_CR62","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1002\/ajmg.a.61627","volume":"182","author":"K Doser","year":"2020","unstructured":"Doser K, Andersen EW, Kenborg L et al (2020) Clinical characteristics and quality of life, depression, and anxiety in adults with neurofibromatosis type 1: a nationwide study. Am J Med Genet A 182(7):1704\u20131715. https:\/\/doi.org\/10.1002\/ajmg.a.61627","journal-title":"Am J Med Genet A"},{"key":"259_CR63","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1477-7525-11-21","volume":"11","author":"K Nutakki","year":"2013","unstructured":"Nutakki K, Hingtgen CM, Monahan P, Varni JW, Swigonski NL (2013) Development of the adult PedsQL neurofibromatosis type 1 module: initial feasibility, reliability and validity. Health Qual Life Outcomes 11:21. https:\/\/doi.org\/10.1186\/1477-7525-11-21","journal-title":"Health Qual Life Outcomes"},{"issue":"11","key":"259_CR64","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1001\/archderm.137.11.1421","volume":"137","author":"P Wolkenstein","year":"2001","unstructured":"Wolkenstein P, Zeller J, Revuz J, Ecosse E, Leplege A (2001) Quality-of-life impairment in neurofibromatosis type 1: a cross-sectional study of 128 cases. Arch Dermatol 137(11):1421\u20131425. https:\/\/doi.org\/10.1001\/archderm.137.11.1421","journal-title":"Arch Dermatol"},{"issue":"3","key":"259_CR65","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1159\/000187594","volume":"218","author":"Y Kodra","year":"2009","unstructured":"Kodra Y, Giustini S, Divona L et al (2009) Health-related quality of life in patients with neurofibromatosis type 1. A survey of 129 Italian patients. Dermatology 218(3):215\u2013220. https:\/\/doi.org\/10.1159\/000187594","journal-title":"Dermatology"},{"issue":"18","key":"259_CR66","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1002\/ajmg.a.31422","volume":"140","author":"PZ Page","year":"2006","unstructured":"Page PZ, Page GP, Ecosse E, Korf BR, Leplege A, Wolkenstein P (2006) Impact of neurofibromatosis 1 on Quality of Life: a cross-sectional study of 176 American cases. Am J Med Genet A 140(18):1893\u20131898. https:\/\/doi.org\/10.1002\/ajmg.a.31422","journal-title":"Am J Med Genet A"},{"issue":"4","key":"259_CR67","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1136\/jmedgenet-2019-106407","volume":"57","author":"EK Bancroft","year":"2020","unstructured":"Bancroft EK, Saya S, Brown E et al (2020) Psychosocial effects of whole-body MRI screening in adult high-risk pathogenic TP53 mutation carriers: a case-controlled study (SIGNIFY). J Med Genet 57(4):226\u2013236. https:\/\/doi.org\/10.1136\/jmedgenet-2019-106407","journal-title":"J Med Genet"},{"issue":"13","key":"259_CR68","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1016\/s0959-8049(98)00294-9","volume":"34","author":"FJ Gilbert","year":"1998","unstructured":"Gilbert FJ, Cordiner CM, Affleck IR, Hood DB, Mathieson D, Walker LG (1998) Breast screening: the psychological sequelae of false-positive recall in women with and without a family history of breast cancer. Eur J Cancer 34(13):2010\u20132014. https:\/\/doi.org\/10.1016\/s0959-8049(98)00294-9","journal-title":"Eur J Cancer"},{"issue":"7","key":"259_CR69","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1200\/JCO.1991.9.7.1275","volume":"9","author":"C Lerman","year":"1991","unstructured":"Lerman C, Rimer BK, Engstrom PF (1991) Cancer risk notification: psychosocial and ethical implications. J Clin Oncol 9(7):1275\u20131282. https:\/\/doi.org\/10.1200\/JCO.1991.9.7.1275","journal-title":"J Clin Oncol"},{"issue":"2","key":"259_CR70","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1177\/104973239600600207","volume":"6","author":"K Chalmers","year":"1996","unstructured":"Chalmers K, Thomson K (1996) Coming to terms with the risk of breast cancer: perceptions of women with primary relatives with breast cancer. Qual Health Res 6(2):256\u2013282. https:\/\/doi.org\/10.1177\/104973239600600207","journal-title":"Qual Health Res"},{"issue":"6","key":"259_CR71","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1177\/1049732314529666","volume":"24","author":"S Hesse-Biber","year":"2014","unstructured":"Hesse-Biber S (2014) The genetic testing experience of BRCA-positive women: deciding between surveillance and surgery. Qual Health Res 24(6):773\u2013789. https:\/\/doi.org\/10.1177\/1049732314529666","journal-title":"Qual Health Res"},{"issue":"17","key":"259_CR72","doi-asserted-by":"publisher","first-page":"4032","DOI":"10.1002\/cncr.33004","volume":"126","author":"N Rippinger","year":"2020","unstructured":"Rippinger N, Fischer C, Haun MW et al (2020) Cancer surveillance and distress among adult pathogenic TP53 germline variant carriers in Germany: a multicenter feasibility and acceptance survey. Cancer 126(17):4032\u20134041. https:\/\/doi.org\/10.1002\/cncr.33004","journal-title":"Cancer"},{"issue":"2","key":"259_CR73","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1136\/eb-2012-100608","volume":"18","author":"M Bond","year":"2013","unstructured":"Bond M, Pavey T, Welch K et al (2013) Psychological consequences of false-positive screening mammograms in the UK. Evid Based Med 18(2):54\u201361. https:\/\/doi.org\/10.1136\/eb-2012-100608","journal-title":"Evid Based Med"},{"issue":"11","key":"259_CR74","doi-asserted-by":"publisher","first-page":"e042696","DOI":"10.1136\/bmjopen-2020-042696","volume":"10","author":"K Hammarberg","year":"2020","unstructured":"Hammarberg K, Tran T, Kirkman M, Fisher J (2020) Sex and age differences in clinically significant symptoms of depression and anxiety among people in Australia in the first month of COVID-19 restrictions: a national survey. BMJ Open 10(11):e042696. https:\/\/doi.org\/10.1136\/bmjopen-2020-042696","journal-title":"BMJ Open"},{"key":"259_CR75","doi-asserted-by":"publisher","first-page":"100351","DOI":"10.1016\/j.invent.2020.100351","volume":"22","author":"L Staples","year":"2020","unstructured":"Staples L, Nielssen O, Kayrouz R et al (2020) Rapid report 2: symptoms of anxiety and depression during the first 12 weeks of the Coronavirus (COVID-19) pandemic in Australia. Internet Interv 22:100351. https:\/\/doi.org\/10.1016\/j.invent.2020.100351","journal-title":"Internet Interv"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-021-00259-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10689-021-00259-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-021-00259-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T22:45:08Z","timestamp":1744152308000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10689-021-00259-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,8]]},"references-count":75,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["259"],"URL":"https:\/\/doi.org\/10.1007\/s10689-021-00259-9","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"type":"print","value":"1389-9600"},{"type":"electronic","value":"1573-7292"}],"subject":[],"published":{"date-parts":[[2021,5,8]]},"assertion":[{"value":"24 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all individuals included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Participants consented to publication of de-identified information on the consent to participate. Only de-identified information included.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Approval was obtained from the Human Research Ethics Committee of Northern Sydney Local Health District. Approval was granted by the ethics committee on 18 June 2018: 2020ETH00762. The procedures used in this study adhere to the tenets of the Declaration of Helsinki.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}